Loading…
Snail and Slug mediate tamoxifen resistance in breast cancer cells through activation of EGFR-ERK independent of epithelial-mesenchymal transition
Breast cancer is the second most common type of cancer and the leading cause of cancer death in women worldwide. Adjuvant tamoxifen therapy significantly slows down estrogen receptor (ER)-positive breast cancer progression, prolongs diseasefree survival, and contributes to the decrease in breast can...
Saved in:
Published in: | Journal of molecular cell biology 2014-08, Vol.6 (4), p.352-354 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Breast cancer is the second most common type of cancer and the leading cause of cancer death in women worldwide. Adjuvant tamoxifen therapy significantly slows down estrogen receptor (ER)-positive breast cancer progression, prolongs diseasefree survival, and contributes to the decrease in breast cancer mortality (Musgrove and Sutherland, 2009). However, majority of the death from breast cancer is due to metastasis that is resistant to therapy (Musgrove and Sutherland, 2009). |
---|---|
ISSN: | 1674-2788 1759-4685 |
DOI: | 10.1093/jmcb/mju019 |